SOFIE, a theranostics company headquartered in Los Angeles, has inked a 9,132-square-foot lease at 21000 Atlantic Boulevard at the Dulles Town Center in Dulles, Va., with landlord Lerner Enterprises, Commercial Observer has learned.
SOFIE is going from a sublease to a prime tenant in the building, and is taking up space on the seventh floor. “In addition to attracting new tenants, including Sallie Mae, the building continues to convert existing sublease tenants to prime tenants, as was the case here,” Mark D. Lerner, a principal of Lerner, said in a statement.
According to CoStar, asking rents are approximately $29.75 to $32 a square foot in the building.
Chris DiBitetto, associate director at Newmark Knight Frank, represented the tenant in the deal, while the landlord was represented by NKF’s Executive Managing Director Andy Klaff and Managing Director Jeff Tarae.
“The building offers immediate access to a full suite of amenities, transportation and an improved surrounding road infrastructure,” Tarae told CO. “A Class A building with amenities is highly attractive to firms looking for options in Loudoun County.” The county is one of the fastest-growing and wealthiest counties in the United States, he said.
Completed in 2001, the seven-story property offers 184,000 square feet in total and tenants include Sallie Mae and Alpha Corporation, as CO reported. The building boasts amenities such as panoramic views, an on-site market, and a fitness studio. It has 70,000 square feet currently being marketed.
The building is located in the heart of the Dulles Town Center mixed-use master plan, nearby the Dulles Town Center mall, The Courtyard by Marriott and several residential communities. It also offers access to Routes 28 and 7, the Dulles Toll Road and Dulles International Airport.
“21000 Atlantic’s location, onsite amenity offering and walkable amenity base of Dulles Town Center continue to be in demand for cutting-edge companies like SOFIE, which is leading the way in the new technology of theranostics,” Lerner said.
SOFIE aims to increase the adoption and application diversity of theranostics, a mash-up of the terms therapy and diagnostics, by reducing the cost and complexity traditionally associated with the medical technology, according to the firm.